BALYASNY ASSET MANAGEMENT L.P. - SAB BIOTHERAPEUTICS INC ownership

SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T111. A total of 17 filers reported holding SAB BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2023$15,770
-5.7%
281,1070.0%0.00%
Q4 2022$16,726
-7.1%
281,1070.0%0.00%
Q3 2022$18,000
-57.1%
281,1070.0%0.00%
Q2 2022$42,000
-67.4%
281,1070.0%0.00%
Q1 2022$129,000
-74.4%
281,1070.0%0.00%
-100.0%
Q4 2021$503,000281,1070.00%
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
LMR Partners LLP 539,588$318,3030.01%
Shaolin Capital Management LLC 498,109$230.00%
EQUITEC PROPRIETARY MARKETS, LLC 45,000$2,1150.00%
Yakira Capital Management, Inc. 108,485$5,0990.00%
WOLVERINE ASSET MANAGEMENT LLC 12,790$6010.00%
MORGAN STANLEY 148,939$7,0010.00%
Walleye Trading LLC 15,505$7290.00%
FLOW TRADERS U.S. LLC 16,013$10.00%
Walleye Capital LLC 23,258$1,0930.00%
Tower Research Capital LLC (TRC) 48$00.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders